Literature DB >> 11579236

T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals.

C M Steffens1, K Y Smith, A Landay, S Shott, A Truckenbrod, M Russert, L Al-Harthi.   

Abstract

BACKGROUND: The adult human thymus contributes to de novo T cell synthesis; such synthesis can be assessed by analyzing T cell receptor excision circles (TREC).
METHODS: TREC levels were measured in total peripheral blood mononuclear cells (PBMC) and CD4- and CD8-enriched cells of 29 HIV-positive patients with maximal viral suppression. The expression of CD45RA+CD45RO-, CD45RA+CD62L+, CD45RO-CD27+CD95low and HLA-DR+CD38+ was assessed using three-color flow cytometric analysis of whole blood. Thymic index score was based on computed tomographic scans of the thymus. The relationship of TREC with thymic index and the expression of the naive phenotypes was evaluated.
RESULTS: TREC expression was not statistically different in these HIV-positive patients from that in age-matched HIV-negative controls. Among HIV-positive patients with CD4 cell count of > 500 x 10(6) cells/l after antiretroviral therapy (n = 15), PBMC TREC levels correlated with the expression of CD45RA+CD45RO- and CD45RA+CD62L+ naive phenotypes, and inversely correlated with the expression of HLA-DR+CD38+. The change between pre- and post-therapy CD4 cell counts for these 15 patients significantly correlated with both thymic index and expression of the CD45RA+CD45RO- phenotype.
CONCLUSIONS: The finding that TREC expression was equivalent between HIV-positive patients after therapy and HIV-negative donors suggests that there is no reduction in thymic output among HIV-positive individuals after therapy. Given that TREC is inversely correlated with HLA-DR/CD38 expression, its analysis in studies of thymopoiesis should be evaluated in the context of maximum viral suppression to reduce HIV-mediated immune activation and/or by normalizing for cell turnover.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11579236     DOI: 10.1097/00002030-200109280-00003

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  14 in total

1.  Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.

Authors:  Akihiko Saitoh; Kumud K Singh; Sharsti Sandall; Christine A Powell; Terrence Fenton; Courtney V Fletcher; Karen Hsia; Stephen A Spector
Journal:  J Allergy Clin Immunol       Date:  2006-04       Impact factor: 10.793

2.  A pilot study of the safety and efficacy of thymosin alpha 1 in augmenting immune reconstitution in HIV-infected patients with low CD4 counts taking highly active antiretroviral therapy.

Authors:  D Chadwick; J Pido-Lopez; A Pires; N Imami; F Gotch; J S Villacian; S Ravindran; N I Paton
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

3.  Longitudinal assessment of de novo T cell production in relation to HIV-associated T cell homeostasis failure.

Authors:  Pratip K Chattopadhyay; Daniel C Douek; Stephen J Gange; Karen R Chadwick; Marc Hellerstein; Joseph B Margolick
Journal:  AIDS Res Hum Retroviruses       Date:  2006-06       Impact factor: 2.205

4.  Homeostasis of the naive CD4+ T cell compartment during aging.

Authors:  Ryan D Kilpatrick; Tammy Rickabaugh; Lance E Hultin; Patricia Hultin; Mary Ann Hausner; Roger Detels; John Phair; Beth D Jamieson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

5.  Assessment of thymic activity in human immunodeficiency virus-negative and -positive adolescents by real-time PCR quantitation of T-cell receptor rearrangement excision circles.

Authors:  Thao Pham; Marvin Belzer; Joseph A Church; Christina Kitchen; Craig M Wilson; Steven D Douglas; Yongzhi Geng; Monica Silva; Richard M Mitchell; Paul Krogstad
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

6.  Decreased levels of recent thymic emigrants in peripheral blood of simian immunodeficiency virus-infected macaques correlate with alterations within the thymus.

Authors:  Donald L Sodora; Jeffrey M Milush; Felecia Ware; Aneta Wozniakowski; Lisa Montgomery; Harold M McClure; Andrew A Lackner; Marta Marthas; Vanessa Hirsch; R Paul Johnson; Daniel C Douek; Richard A Koup
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Increased peripheral expansion of naive CD4+ T cells in vivo after IL-2 treatment of patients with HIV infection.

Authors:  Ven Natarajan; Richard A Lempicki; Irini Sereti; Yunden Badralmaa; Joseph W Adelsberger; Julia A Metcalf; Darue A Prieto; Randy Stevens; Michael W Baseler; Joseph A Kovacs; H Clifford Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

8.  Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs.

Authors:  Alan Landay; Lorie Benning; James Bremer; Barbara Weiser; Harold Burger; Marek Nowicki; Andrea Kovacs
Journal:  J Infect Dis       Date:  2003-07-01       Impact factor: 5.226

9.  Immune Restoration Inflammatory Syndromes: The Dark Side of Successful Antiretroviral Treatment.

Authors:  Matthias Stoll; Reinhold E. Schmidt
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

10.  CD1d-restricted natural killer T cells are potent targets for human immunodeficiency virus infection.

Authors:  Richardson Fleuridor; Brian Wilson; Runhua Hou; Alan Landay; Harold Kessler; Lena Al-Harthi
Journal:  Immunology       Date:  2003-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.